FDA Recalls Antibiotic Drug Sulfamethoxazole and Trimethoprim for Packaging Contamination
The FDA is recalling a specific lot of Sulfamethoxazole and Trimethoprim due to presence of a micro-organism in the auxiliary polyester coil packaging material. No micro-organism was detected on the tablets themselves.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving a micro-organism detected in product packaging material. Although no contamination was found on the tablets themselves and no illnesses have been reported, it represents a risk-of-harm situation. Per the rubric, recalls with no reported illnesses and theoretical hazards score at most 3.
Plain-English summary
The FDA is recalling a specific lot of Sulfamethoxazole and Trimethoprim (Double Strength, 800 mg/160 mg) tablets due to detection of a micro-organism in the auxiliary polyester coil used in product packaging. The affected lots are Bag: N02309A and N02309B with expiration date 03/31/2027; Inner blister Lot # N02309 with expiration date 03/31/2027. Importantly, no micro-organism was detected on any of the tablets themselves.
The recalled product was distributed nationwide throughout the United States. The product is an antibiotic used to treat bacterial infections and is available by prescription only. It is distributed by Cardinal Health, Dublin, OH 43017.
Consumers and healthcare providers who have this medication should not use the affected lots. Patients should contact their healthcare provider or pharmacist about alternative treatment options. The medication should be returned to the pharmacy where it was purchased or disposed of according to local regulations.
The recalled product
- Product
- SULFAMETHOXAZOLE AND TRIMETHOPRIM (SULFAMETHOXAZOLE AND TRIMETHOPRIM)
- Brand
- SULFAMETHOXAZOLE AND TRIMETHOPRIM
- Manufacturer
- The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
- Category
- Drug — Antibiotic
- Hazard
- contamination
- micro-organism
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Bag: N02309A and N02309B
- Exp Date: 03/31/2027
- Inner blister: Lot # N02309
UPCs (1)
- 0055154789509
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SULFAMETHOXAZOLE AND TRIMETHOPRIM
- ModeratePrescription Antibiotic Tablets Recalled for Packaging Material Contamination
FDA (Drugs) · 2025-09-24
- ModerateAntibiotic Drug Tablets Recalled Due to Microbial Contamination in Packaging
FDA (Drugs) · 2025-09-17
- ModeratePrescription antibiotic tablets recalled due to packaging contamination
FDA (Drugs) · 2025-09-10
- SevereAntibiotic Tablets Recalled Nationwide for Microbial Contamination
FDA (Drugs) · 2025-06-18
- HighPrescription Antibiotic Tablets Recalled Due to Temperature Abuse
FDA (Drugs) · 2022-06-15
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27